Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 50530 | 18.54 |
09:34 ET | 25908 | 18.8 |
09:36 ET | 23946 | 18.82 |
09:38 ET | 43616 | 18.98 |
09:39 ET | 38422 | 18.9808 |
09:41 ET | 27887 | 18.99 |
09:43 ET | 42766 | 19.22 |
09:45 ET | 61401 | 19.41 |
09:48 ET | 48874 | 19.285 |
09:50 ET | 36340 | 19.28 |
09:52 ET | 30783 | 19.26 |
09:54 ET | 14054 | 19.195 |
09:56 ET | 22244 | 18.97 |
09:57 ET | 25063 | 18.92 |
09:59 ET | 11805 | 19.02 |
10:01 ET | 33259 | 19.13 |
10:03 ET | 31991 | 19.13 |
10:06 ET | 21767 | 19.18 |
10:08 ET | 25091 | 19.18 |
10:10 ET | 28770 | 19.16 |
10:12 ET | 10668 | 19.18 |
10:14 ET | 35565 | 19.135 |
10:15 ET | 33394 | 19.19 |
10:17 ET | 8155 | 19.175 |
10:19 ET | 1200 | 19.175 |
10:21 ET | 11366 | 19.185 |
10:24 ET | 5031 | 19.22 |
10:26 ET | 24739 | 19.14 |
10:28 ET | 20567 | 19.18 |
10:30 ET | 20297 | 19.201 |
10:32 ET | 7932 | 19.17 |
10:33 ET | 3330 | 19.175 |
10:35 ET | 11407 | 19.16 |
10:37 ET | 23171 | 19.19 |
10:39 ET | 15372 | 19.1401 |
10:42 ET | 19915 | 19.15 |
10:44 ET | 23693 | 19.22 |
10:46 ET | 14111 | 19.2 |
10:48 ET | 3693 | 19.16 |
10:50 ET | 37661 | 19.14 |
10:51 ET | 32642 | 19.1065 |
10:53 ET | 19214 | 19.21 |
10:55 ET | 9939 | 19.18 |
10:57 ET | 10663 | 19.2499 |
11:00 ET | 26062 | 19.26 |
11:02 ET | 5359 | 19.28 |
11:04 ET | 4811 | 19.27 |
11:06 ET | 4477 | 19.3 |
11:08 ET | 10376 | 19.32 |
11:09 ET | 10059 | 19.3 |
11:11 ET | 2876 | 19.29 |
11:13 ET | 15627 | 19.2099 |
11:15 ET | 1602 | 19.215 |
11:18 ET | 8556 | 19.1901 |
11:20 ET | 5490 | 19.215 |
11:22 ET | 14525 | 19.23 |
11:24 ET | 11749 | 19.26 |
11:26 ET | 1108 | 19.2301 |
11:27 ET | 5834 | 19.19 |
11:29 ET | 3185 | 19.18 |
11:31 ET | 11771 | 19.16 |
11:33 ET | 4169 | 19.15 |
11:36 ET | 9453 | 19.17 |
11:38 ET | 5235 | 19.16 |
11:40 ET | 10935 | 19.162 |
11:42 ET | 2007 | 19.18 |
11:44 ET | 3908 | 19.14 |
11:45 ET | 9446 | 19.14 |
11:47 ET | 25741 | 19.15 |
11:49 ET | 58422 | 18.95 |
11:51 ET | 19559 | 18.84 |
11:54 ET | 14001 | 18.97 |
11:56 ET | 11235 | 19 |
11:58 ET | 10565 | 18.9466 |
12:00 ET | 2460 | 18.96 |
12:02 ET | 1400 | 18.94 |
12:03 ET | 2568 | 18.97 |
12:05 ET | 4249 | 18.95 |
12:07 ET | 3154 | 18.94 |
12:09 ET | 800 | 18.93 |
12:12 ET | 10265 | 18.94 |
12:14 ET | 1800 | 18.94 |
12:16 ET | 5226 | 18.84 |
12:18 ET | 4982 | 18.9 |
12:20 ET | 6936 | 18.92 |
12:21 ET | 1819 | 18.94 |
12:23 ET | 6900 | 18.9999 |
12:25 ET | 10681 | 18.93 |
12:27 ET | 8430 | 18.965 |
12:30 ET | 93916 | 19.14 |
12:32 ET | 38674 | 19.12 |
12:34 ET | 14121 | 19.065 |
12:36 ET | 9756 | 19.06 |
12:38 ET | 11634 | 19.14 |
12:39 ET | 13192 | 19.1399 |
12:41 ET | 2100 | 19.14 |
12:43 ET | 3225 | 19.16 |
12:45 ET | 6988 | 19.189 |
12:48 ET | 6650 | 19.175 |
12:50 ET | 4430 | 19.1745 |
12:52 ET | 5375 | 19.245 |
12:54 ET | 5347 | 19.25 |
12:56 ET | 3371 | 19.2399 |
12:57 ET | 7171 | 19.2407 |
12:59 ET | 898 | 19.24 |
01:01 ET | 2219 | 19.2 |
01:03 ET | 4297 | 19.19 |
01:06 ET | 1865 | 19.17 |
01:08 ET | 18551 | 19.24 |
01:10 ET | 3746 | 19.25 |
01:12 ET | 7695 | 19.23 |
01:14 ET | 7797 | 19.23 |
01:15 ET | 3617 | 19.23 |
01:17 ET | 12862 | 19.21 |
01:19 ET | 15723 | 19.23 |
01:21 ET | 3264 | 19.25 |
01:24 ET | 2850 | 19.2521 |
01:26 ET | 4155 | 19.25 |
01:28 ET | 1829 | 19.27 |
01:30 ET | 7512 | 19.29 |
01:32 ET | 10221 | 19.23 |
01:33 ET | 1800 | 19.22 |
01:35 ET | 1111 | 19.25 |
01:37 ET | 2422 | 19.25 |
01:39 ET | 1207 | 19.24 |
01:42 ET | 950 | 19.22 |
01:44 ET | 1243 | 19.245 |
01:46 ET | 7585 | 19.25 |
01:48 ET | 769 | 19.24 |
01:50 ET | 2427 | 19.23 |
01:51 ET | 1300 | 19.2 |
01:53 ET | 6524 | 19.2 |
01:55 ET | 2093 | 19.23 |
01:57 ET | 4051 | 19.2375 |
02:00 ET | 17976 | 19.23 |
02:02 ET | 1069 | 19.23 |
02:04 ET | 1778 | 19.21 |
02:06 ET | 15842 | 19.15 |
02:08 ET | 9490 | 19.1 |
02:09 ET | 1397 | 19.1098 |
02:11 ET | 1255 | 19.14 |
02:13 ET | 3807 | 19.13 |
02:15 ET | 3453 | 19.15 |
02:18 ET | 3363 | 19.17 |
02:20 ET | 7094 | 19.17 |
02:22 ET | 2618 | 19.16 |
02:24 ET | 1200 | 19.15 |
02:26 ET | 17082 | 19.14 |
02:27 ET | 11525 | 19.12 |
02:29 ET | 2250 | 19.14 |
02:31 ET | 5122 | 19.08 |
02:33 ET | 9000 | 19.1201 |
02:36 ET | 1403 | 19.1105 |
02:38 ET | 7493 | 19.15 |
02:40 ET | 8825 | 19.12 |
02:42 ET | 2266 | 19.12 |
02:44 ET | 8403 | 19.12 |
02:45 ET | 2333 | 19.085 |
02:47 ET | 1014 | 19.07 |
02:49 ET | 1531 | 19.08 |
02:51 ET | 8890 | 19.07 |
02:54 ET | 2200 | 19.06 |
02:56 ET | 32420 | 19.08 |
02:58 ET | 2663 | 19.05 |
03:00 ET | 9930 | 19.05 |
03:02 ET | 7967 | 19.06 |
03:03 ET | 7842 | 19.05 |
03:05 ET | 12725 | 19.09 |
03:07 ET | 4328 | 19.12 |
03:09 ET | 14183 | 19.12 |
03:12 ET | 1948 | 19.1035 |
03:14 ET | 4550 | 19.12 |
03:16 ET | 2050 | 19.14 |
03:18 ET | 2918 | 19.1601 |
03:20 ET | 5839 | 19.15 |
03:21 ET | 16504 | 19.12 |
03:23 ET | 4508 | 19.08 |
03:25 ET | 14789 | 19.15 |
03:27 ET | 300 | 19.15 |
03:30 ET | 5856 | 19.14 |
03:32 ET | 5815 | 19.18 |
03:34 ET | 5009 | 19.17 |
03:36 ET | 6608 | 19.1556 |
03:38 ET | 4512 | 19.1507 |
03:39 ET | 8740 | 19.155 |
03:41 ET | 8997 | 19.2 |
03:43 ET | 8965 | 19.19 |
03:45 ET | 11452 | 19.2 |
03:48 ET | 10203 | 19.16 |
03:50 ET | 8229 | 19.1523 |
03:52 ET | 23158 | 19.13 |
03:54 ET | 14803 | 19.16 |
03:56 ET | 16151 | 19.175 |
03:57 ET | 20876 | 19.2 |
03:59 ET | 235665 | 19.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 3.0B | 87.0x | --- |
Twist Bioscience Corp | 2.8B | -14.3x | --- |
MorphoSys AG | 2.7B | -5.3x | --- |
Arrowhead Pharmaceuticals Inc | 3.3B | -6.3x | --- |
ADMA Biologics Inc | 2.6B | -539.7x | --- |
Denali Therapeutics Inc | 3.2B | -23.2x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.0B |
---|---|
Revenue (TTM) | $289.3M |
Shares Outstanding | 154.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.24 |
EPS | $0.22 |
Book Value | $1.06 |
P/E Ratio | 87.0x |
Price/Sales (TTM) | 10.3 |
Price/Cash Flow (TTM) | 71.7x |
Operating Margin | 16.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.